These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18812096)

  • 1. Laboratory data and statistical evidence in fluoroquinolone study.
    O'Callaghan R; Ohnsman C; Song J
    J Cataract Refract Surg; 2008 Oct; 34(10):1617-8; author reply 1618. PubMed ID: 18812096
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
    Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ
    J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative lidocaine gel.
    Awotesu S; Eke T
    Ophthalmology; 2010 May; 117(5):1049; author reply 1049. PubMed ID: 20438969
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.
    Kodjikian L; Garweg JG
    Am J Ophthalmol; 2006 Apr; 141(4):777; author reply 777-8. PubMed ID: 16564833
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis.
    Karaküçük S; Mirza E; Sümerkan B; Okten T
    Ophthalmic Res; 2000; 32(2-3):126-31. PubMed ID: 10754446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Sasaki H; Fukuda M; Gordon YJ
    Jpn J Ophthalmol; 2008; 52(3):211-216. PubMed ID: 18661272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental intracameral injection of vancomycin microparticles in rabbits.
    Kodjikian L; Couprie J; Hachicha W; Timour Q; Devouassoux M; Builles N; Hartmann D; Fessi H
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4125-32. PubMed ID: 20335605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of fluoroquinolones to nonfluoroquinolone antibacterial agents for the prevention of endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Shanks RM; Mah FS
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):604-8. PubMed ID: 22925112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis.
    Wu X; Chen H; Jiang H; Xu Y; Liu T; Xu L
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):186-93. PubMed ID: 22077488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits.
    Hatano H; Inoue K; Shia S; Liping W
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):666-70. PubMed ID: 8109214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual lens cortex material: potential risk factor for endophthalmitis after phacoemulsification cataract surgery.
    Lou B; Lin X; Luo L; Yang Y; Chen Y; Liu Y
    J Cataract Refract Surg; 2013 Feb; 39(2):250-7. PubMed ID: 23228593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.
    Moss JM; Sanislo SR; Ta CN
    Ophthalmology; 2009 Aug; 116(8):1498-501. PubMed ID: 19501409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
    Tsuchiya Y; Kobayakawa S; Tsuji A; Tochikubo T
    Curr Eye Res; 2008 Oct; 33(10):868-75. PubMed ID: 18853321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anterior chamber air bubble on prevention of experimental Staphylococcus epidermidis endophthalmitis.
    Mehdizadeh M; Rahat F; Khalili MR; Ahmadi F
    Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):277-81. PubMed ID: 19821164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endophthalmitis.
    Bohigian GM
    Ophthalmology; 2008 Feb; 115(2):413-4; author reply 414. PubMed ID: 18243911
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.